PKI-587 (Gedatolisib)

SKU: C-1270-5mg

Quantity (mg):

5 mg

Product Options

Quantity

$149.99

Catalog#: C-1270

Targets: PI3K

Synonym: PKI587; PKI-587; PKI 587; PF05212384; PF-05212384; PF 05212384; PF5212384; PF-5212384; PF 5212384; Gedatolisib

Chemical Name/IUPAC:1-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea

Technical Data

Product Name: PKI-587 (Gedatolisib)

Chemical Formula: C32H41N9O4

Molecular Weight: 615.72

CAS#: 1197160-78-3

Appearance: Solid powder

Purity: > 99% by HPLC

Solubility: Soluble in DMSO

Storage: Room temperature for months, or -20ºC for 3 years

Description
PKI-587 (Gedatolisib) is an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Upon intravenous administration, PI3K/mTOR kinase inhibitor PKI-587 inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR.

PKI-587 (Gedatolisib)

Related products

A-1210477

ABT-199 (Venectoclax)

ABT-263 (Navitoclax)

ABT-737